Aptevo Therapeutics (APVO) Receivables (2016 - 2019)
Historic Receivables for Aptevo Therapeutics (APVO) over the last 5 years, with Q4 2019 value amounting to $7.0 million.
- Aptevo Therapeutics' Receivables rose 3452.11% to $7.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $7.0 million, marking a year-over-year increase of 3452.11%. This contributed to the annual value of $7.0 million for FY2019, which is 3452.11% up from last year.
- As of Q4 2019, Aptevo Therapeutics' Receivables stood at $7.0 million, which was up 3452.11% from $7.9 million recorded in Q3 2019.
- Aptevo Therapeutics' Receivables' 5-year high stood at $8.5 million during Q2 2016, with a 5-year trough of $307000.0 in Q4 2016.
- For the 5-year period, Aptevo Therapeutics' Receivables averaged around $4.8 million, with its median value being $5.5 million (2018).
- Per our database at Business Quant, Aptevo Therapeutics' Receivables crashed by 9524.47% in 2016 and then soared by 107462.12% in 2018.
- Quarter analysis of 5 years shows Aptevo Therapeutics' Receivables stood at $6.5 million in 2015, then tumbled by 95.24% to $307000.0 in 2016, then skyrocketed by 597.39% to $2.1 million in 2017, then soared by 143.81% to $5.2 million in 2018, then surged by 34.52% to $7.0 million in 2019.
- Its Receivables stands at $7.0 million for Q4 2019, versus $7.9 million for Q3 2019 and $7.4 million for Q2 2019.